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A relationship between stratum corneum reservoir 
function and percutaneous absorption has been estab-
lished in the hairless rat. Two hundred nanomoles of 10 
substances that have a wide range of chemical structures 
were topically applied for 30 min and the total body 
distribution was measured after 96 h. The quantity of 
substance present in the stratum corneum reservoir 
after 30-min application was measured by liquid scin-
tillation counting after tape-stripping the treated area. 
A linear relationship exists between the quantity of 
substance in this reservoir x(nmol· cm-2 ) and the total 
amount of radioactivity distributed in the body and ex-
creta y(nmol- cm-2 ) after 96 h. The relationship is given 
by: y = 1.644 x x- 0.536 (r = 0.998,p < 0.001). Apart 
from the steroids, 80-95% of the compounds were ex-
creted in the urine; and with the exception of thiourea, 
this elimination was rapid, especially for mannitol and 
benzoic acid. 
We confirmed that in terms of penetration there is a 
factor of 50 between benzoic acid (best) and dexameth-
asone (worst). Thus the quantity of substance penetrat-
ing through intact rat skin can be predicted by measur-
ing the horny layer concentration. The animal data re-
ported here should be verified in humans. 
There is considerable evidence to suggest that the most 
important barrier to drug penetration through the skin is t he 
stratum corneum [1-4], which also acts as a reservoir for 
molecules applied on t h e skin [5-7]. These functions then seem 
closely related [6-9]. 
The results obtained from various existi ng methods used for 
measuring the in vivo penetration, for a given product, are 
rarely comparable. This is due essentially to the diversity of 
techniques used, animal species [10,11], anatomical location 
[1 ,12], concentration of the molecules tested [13,14), vehicle 
used [10,15], and duration of the experiment [10). Furthermore, 
experience has shown that it is very difficult to extrapolate to 
humans the results obtained with animals [16-18). 
Considering these facts, we asked ourselves, prior to human 
studies, whether there was a possible relationship between the 
stratum corneum reservoir function and the molecule penetra-
tion in a single species, the h airless rat, under exactly defined 
experimental conditions. 
MATERIALS AND METHODS 
Materials 
We chose to test molecules having very different physicochemical 
properties and belonging to different chemical classes. Ten radiolabeled 
molecules from The Raruochemical Centre Amersham (U.K.) were 
studied: [1 ,2-3H ]dexamethasone, [1,2,6,7-3H ]hydrocortisone, [1,2-3H ]-
dehydroepiandrosterone, ["C]testosterone, [carboxyl-"C]acetylsali-
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cylic acid, [carboxyl- 1'C]sodium salicylate, [8-3H]caffeine, [ring- 14C]-
benzoic acid, D-[1- 14C]mannitol, [14C]thiourea. 
For each product, a group of 12 female hairless Sprague-Dawley 
(OFA) rats, aged 12 weeks, weighing 240 ± 10 g was used. 
Application Conditions 
The molecules were applied on 1 cm 2 of dorsal skin; the animals had 
previously been anesthetized by 0.5 ml/kg i.p. injection of ')'-butyrolac-
tone. The surface of application was delimited by an open circular cell 
(S = 1 cm2) fixed by si licone glue (Tecsil). The vehicle, ethanol-water 
95/5 (v/ v), was chosen according to the solubility of the products with 
t he exception of D-mannitol which was dissolved in ethanol-water 25/ 
75 (v/v) and of sodium salicylate dissolved in ethanol-water 50/ 50 (v/ 
v). 
The standard dose applied was 200 nmol.cm- 2, with the exception of 
benzoic acid which was applied at 200 and 450 nmol.cm- 2• The vehicle 
volati lity limits the application period to 30 mins. After this time, the 
excess product on the applied area was rapidly removed by 2 washings 
(300 J.L l) with the vehicle solvent, followed by 2 rinsings (300 J.Ll) with 
distilled water and light drying with cotton wool. 
Conditions for the Percutaneous Absorption Measurements 
At the end of the application and washing, the 12 animals were 
divided into 2 equal groups. The stratum corneum of the application 
area of the animals from the first group was removed by 6 strippings 
using "3 M" invisible adhesive tape. Previous histologic studies have 
shown that th is technique removes most of the stratum corneum, the 
horny layer of the hairless rat skin being composed of 7- 8 cellular 
layers (thickness= 10- 15 J.Lin). 
The amount of substance contained in the stratum corneum after a 
30-min application was determined as follows. The radioactivity on 
each strip was measured after complete digestion of the keratinic 
material in Soluene 350 (Packard), addition of Dimilume 30 (Packard) , 
and liquid scin ti llation counting (Packard 460 C). 
The animals of the second group, equipped with collars to prevent 
licking, were placed inruvidually in metabolism cages for 4 days. During 
this t ime, food (Extra Labo) and tap water were provided ad libitum. 
Urinary excretion was established by daily sampling of the urine and 
liquid scintillation counting. The feces were collected daily, pooled, and 
counted by liquid scintillation after lyophilization, homogenization, 
and combustion of the samples with an Oxidizer 306 (Packard). Four 
days later, the animals were sacrified by cervical dislocation. Series of 
6 strippings were performed on the t reated area in order to determine 
the amount of product not passed through the stratum corneum barrier 
within 96 h. The remaining skin of t he treated area (epidermis + 
dermis) was sampled and counted by liquid scinti llation after digestion 
in Soluene 350 (Packard) . The animals were lyophi lized, homogenized, 
a nd the samples were counted in liquid scintillation after combustion. 
For the tritiated molecules, radioactivity in the water of lyophilization 
was counted, to determine for each case the tritium exchange. 
The total amount of substance penetrating in 96 h was determined 
by adding the amounts found in the excreta (urine + feces) , in the 
epidermis and dermis of the appl ication area and in the whole animal 
body. 
RESULTS 
The urinary excretion kinetics of the different substances 
studied are shown in Table I. 
Table II shows the distribution of the tested molecules in 
urinary and fecal excretions as well as their whole body reten-
tion; the penetration rate (illustrated by Fig 1) of the molecules 
96 h after their topical application; as well as the amoun ts of 
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products present in the stratum corneum at the end of the 
application ,period (30 min) . . 
Fig 2 represents the linear relationship between penetration 
of the substance after 4 days and its level in the stratum 
corneum at the end of the 30-min application period. 
DISCUSSION 
The substances tested were chosen because of the wide 
variety in their structure and physicochemical properties, and 
TABLE I. Kinetics of urinary excretion of molecules after topical 
administration 
Urinary excretion 
Molecules (time in hours) 
0-24 24-48 48- 72 72- 96 
Benzoic acid 
450 nmol-cm-2 61.00a 5.60 2.80 1.77 
(2.50)b (0.90) (0.45) (0.37) 
200 nmol -cm-2 22.95 0.75 0.66 0.43 
(0.55) (0.06) (0.07) (0.04) 
Acetylsalicylic ac id 3.30 1.20 0.53 0.35 
(0.45) (0.20) (0.06) (0.08) 
Dehydroepiandrosterone 0.95 0.43 0.18 0.10 
(0.08) (0.07) (0.01) (0.02) 
Sodium salicylate 1.86 0.58 0.60 0.46 
(0.50) (0.18) (0.17) (0.07) 
Testosterone 0.92 0.48 0.20 0.14 
(0.29) (0.07) (0.04) (0.02) 
Caffeine L80 0.39 0.19 0.14 
(0.23) (0.04) (0.02) (0.01) 
Thiourea 0.74 0.84 0.30 0.19 
(0.18) (0.19) (0.05) (0.02) 
D-Mannitol 1.30 0.09 0.10 0.08 
(0.22) (0.01) (0.02) (0.01) 
Hydrocortisone 0.29 0.09 0.06 0.03 
(0.09) (0.03) (0.01) (0.009) 
Dexamethasone 0.04 0.035 0.035 0.055 
(0.004) (0.008) (0.004) (0.010) 
a Expressed in nmol· cm-2 application area. 
bSD (n = 6). 
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because their penetration ability covers a very large range (1-
50). The urinary excretion kinetics (Table I) show that, except 
for thiourea, these substances are rapidly eliminated. This 
elimination is particularly fast in the case of benzoic acid and 
D-mannitol. It is important to comment on how the elimination 
of the substance, particularly by urinary and fecal excretion 
(Table II). Except for the steroids, the substances tested are 
eliminated 80-95% by the urinary pathway, although their 
physicochemical properties differ. 
The percutaneous absorption results, in agreement with 
those obtained in the literature, show that after 96 h there are 
large differences in the amounts of substances that have pene-
trated through the skin (Table II, Fig 1) . The rank order 
established in humans by Feldmann et al [19] in the level of 
steroid penetration-dexamethasone, hydrocortisone, testos-
terone, and dehydroepiandrosterone-is seen again in our re-
sults in rat. Furthermore, hydrocortisone penetrates 5 times 
less than testosterone and dehydroepiandrosterone which have 
almost identical penetrating properties. This agreement with 
the literature is also verified for acetylsalicyclic acid and ben-
zoic acid, the latter known to be very well absorbed [20]. 
Likewise, it is known that acetylsalicylic acid and salicylic acid 
have similar penetrating properties [20], whereas their sodium 
salts exhibit diminished penetration [21] and, indeed, we ob-
served that sodium salicylate penetrates less than acetylsali-
cylic acid. 
It has been established that the penetration of a compound 
increases with the amount applied [13,14]. This phenomenon 
has been observed in the case of benzoic acid when applied at 
200 and 450 nmol.cm- 2 • 
Despite good agreement ofthe percutaneous absorption rank-
ing of some substances in animals with the ranking established 
in humans, extrapolations in absolute values remain proble-
matic. In fact, there are many examples of substances, which, 
penetrating weakly in animal, can be carried in large amounts 
through the human skin and vice versa. As an example, in 
humans, caffeine penetrates approximately 50 times more than 
thiourea and has almost the same absorption rate as benzoic 
acid [20] . In the rat, our results have shown that penetrations 
TABLE II. Parameters of percutaneous absorption of molecules 
Total amounts found 96 hours after topical application Amounts in 
stratum corneum 
Molecules Epidermis + Total treated area Urine Feces dermis area Animal body penetration 30 min afte r treated application 
Benzoic acid 
450 nmol -cm- 2 71.20a 6.25 1.70 0.16 79.30 48.10 
(2.9W (1.65) (0.40) (0.02) (3.60) (5.10) 
200 nmol-cm- 2 24.80 1.32 0.50 0.01 26.60 17.60 
(0.50) (0.30) (0.05) (0.004) (0.70) (1.50) 
Acetylsalicylic acid 5.40 0.43 0.85 0 6.70 5.15 
(0.70) (0.15) (0.20) (0.70) (0.64) 
Dehydroepiandrosterone 1.67 3.00 0.19 0.43 5.28 1.95 
(0.15) (0.30) (0.03) (0.08) (0.20) (0.40) 
Sodium salicylate 3.50 0.48 1.00 0 4.98 3.85 
(0.50) (0.10) (0.17) (0.71) - (0.29) 
Testosterone 1.72 2.05 0.24 0.33 4.32 2.06 
(0.43) (0.60) (0.05) (0.15) (0.46) (0.23) 
Caffeine 2.52 0.42 0.15 0.65 3.73 2.76 
(0.25) (0.07) (0.01) (0.06) (0.30) (0.34) 
Thiourea 2.10 0.76 0.20 0.20 3.23 2.63 
(0.40) (0.04) (0.02) (0.04) (0.48) (0.33) 
D-Mannitol 1.60 0.42 0.30 0.30 2.63 2.22 
(0.20) (0.15) (0.10) (0.10) (0.17) (0.37) 
Hydrocortisone 0.46 0.33 0.04 0.03 0.86 0.93 
(0.07) (0.07) (0.01) (0.01) (0.08) (0.15) 
Dexamethasone 0.16 0.30 0.10 0.04 0.60 0.41 
(0.02) (0.05) (0.02) (0.01) (0.06) (0.02) 
a Expressed in nmol -cm- 2 application area. 
bSD (n = 6) . 
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FIG 1. Total percutaneous absorption levels (nmol.cm-2) of the 
prod~cts tested 96 h after their topical application on the hairless rat. 
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FIG 2. Correlation between the level of penetration of the products 
after 96 h and their concentration in the stratum corneum after 30 min 
of application (decimal scale). 
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of caffeine, testosterone, and thiourea are similar, i.e., 7 times 
less than that of benzoic acid. These findings clearly illustrate 
species differences. 
The total amount of substances present at the end of appli-
cation (30 m in) in the reservoir constituted by the stratum 
corneum has been determined by adding the amounts in each 
strip (Table II). The formation of significant substance reser-
voir within the horny layer may be due to the existence of 
differences between the substances in their vehicle-stratum 
corneum partition coefficients [8,15], to the different permea-
bilities of the vehicles in which the molecules are solubilized 
(7,10], to the particular affinity that a compound may have for 
the horny layer [22,23], or to the combined action of these 
different factors. 
The most important feature of this study is that there is a 
linear relationship between "the horny layer reservoir effect" 
at the end of the application period (30 min) (x) and the total 
amounts of substances penetrating within 96 h (y), independ-
ently of the nature of the tested molecule. The linear relation-
ship between the amount of substance penetrating and the 
amount of substance in the horny layer is of y = a x x + b 
type, where a = 1.644 and b = - 0.536 (y and x being expressed 
in nmol.cm- 2 ) . These two variables are correlated with a coef-
ficient of 0.998 and a p < 0.001 (Fig 2). 
In conclusion, the experimental data show that measuring 
the amount of a substance within the stratum corneum at the 
end of the application time (30 min) gives a good prediction 
assessment of the total amount penetrating in 4 days. This 
relationship, verified in a single animal species (rat), should 
now be tested in humans. For technical reasons, the experi-
ments have been carried out using labeled molecules. However, 
the re latively large amounts of substance present in the " res-
ervoir" of the stratum corneum at the end of the application 
time should allow penetration studies in both humans and 
animals, by sensitive nonradioactive techniques. 
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An Estimate of the Melanocyte Mass in Humans 
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Departments of Dermatology, University of Gothenburg, Gothenburg, and University of Lund, Lund, Sweden 
The size of the melanocyte system in humans was 
estimated as though all active melanocytes in the body 
were assembled in a single compact organ. Our estimates 
indicate that the epidermal melanocytes constitute the 
dominant part of the "melanocyte organ." In an adult 
human not recently exposed to sunlight , the functionally 
active epidermal melanocytes form a tissue 1.0-1.5 cm3 • 
Other melanocytes, such as those in the mucous mem-
branes, the follicles, and the eyes, constitute only a small 
proportion of the total melanocyte cell mass. 
During the last deca de it has become possible to identify 
several metabolic products originating from m elanocytes 
[1-3]. Generally these substances h ave been considered as 
inactive "side-products" of the pigment syn t hesis, but they may 
we ll have biologic effects outside the immediate vicinity of the 
syn t hesizing melanocyte. The recent finding, that repeated UV 
irradiation of a restricted skin a rea induces delayed melanocyte 
proliferation in shielded skin areas, m ay be an example of such 
remote control via circulating fac tors [4). An analogous phe-
n omen on could be t he de layed increase in serum concentrations 
of 5-S-cysteinyldopa following PUV A (psora le n + UV A) treat-
ment of a limited skin area in huma ns [5]. 
With t his background it seemed interesting to obtain some 
idea of the total s ize of the active melanocyte system. This is 
di fficu lt to ac hieve intuitively, because the m elanocytes a re 
dispersed as indiv idual cells. W e h ave tried to estimate the size 
of the system as t hough a ll pigment-producing mela nocytes in 
t he body were assembled in a single compact organ. This 
approach should a llow more concrete comparison with other 
organ s a nd might a lso give an indicat ion of the s ize of mela-
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noma metastasis that can be detected by measureme n ts of 
biochemical markers in the urine of patients with m e la n oma 
[6,7]. W e concentrated our calculation s on the epiderm a l m e-
lanocyte population, because a rough estimate indicates that 
the epidermal and follicular m e lanocytes constitute t he over-
whelming proportion of t he pigment-forming mela nocytes in 
the body [8-11 ). 
MATERIALS AND METHODS 
Epidermal Melanocyte Population Density 
The number of epidermal melanocytes per mm2 was estimated in 
dopa-incubated split-skin preparations [12,13]. A tota l of 20 skin 
biopsies were taken from t he buttock, arm, back, thigh, face, and 
genitals of 18 male donors aged 25- 46 (mean 31) years. The donors 
had not been exposed to tanning sunlight for 5 months prior to 
obtaining the biopsies. In each preparation melanocyte counts were 
made over 10 square ocular fi elds using objectives 25X or 40X [1 2]. 
The proportion of t he skin surface covered by melanocytes was 
estimated in the same preparation by a random sampling procedure, 
using a 40X objective and an ocular plate containing 25 randomly 
distributed spots arranged in a circle (G 52, Chalkley Point Array, 
Leitz). With this plate t he number of spots superimposed on melano-
cyte bodies was counted over 10 randomly selected ftelds in each 
preparation. The proport ion of positive poin ts gives a direct measure 
of t he relative skin area covered by melanocyte cell bodies. 
To estimate t he overall change in size of t he split-skin preparation, 
we compared t he diameters of the mounted split -skin specimens wi th 
the diameter of t he biopsy punch (3.0 mm) . The mean diameter of the 
mounted specimens was 3.2 mm (2.9- 3.4 mm), indicating t hat slight 
overall swelling of the preparation had taken place. 
The Size of the Epidermal Melanocyte 
The typical epidermal melanocyte is roughly spindle-shaped, with 
the long axis parallel to the basal lamina of the epidermis. We estimated 
t he mean volume of the cell by measuring 3 axes: the length and 
breadth in the plane parallel to the surface, and the height at right 
angles to this plane. The two first-named measures were obtained from 
dopa-incubated split-skin preparations. The height was measured in 
the skin sections taken from the same specimens. These specimens 
were not dopa-incubated, but immediately fixed in 3% glutaraldehyde, 
embedded in Epon, and 3-,.,m sections were cut. An ocular micrometer 
was used for all measurements. The mean size of the melanocytes from 
